Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 14, 2008; 14(22): 3554-3562
Published online Jun 14, 2008. doi: 10.3748/wjg.14.3554
Published online Jun 14, 2008. doi: 10.3748/wjg.14.3554
Table 1 The mean weight in four groups (g)
Groups | Before treatment | After treatment (d) | |||
3 | 7 | 10 | 14 | ||
NS | 20.96 ± 0.82 | 22.35 ± 1.17 | 23.41 ± 1.53 | 24.28 ± 1.72 | 24.11 ± 1.73 |
5-Fu | 22.16 ± 2.83 | 22.20 ± 2.86 | 22.58 ± 2.80 | 20.86 ± 3.16 | 18.34 ± 3.69 |
CTS-Pasp | 20.80 ± 1.19 | 22.96 ± 1.34 | 24.45 ± 1.26 | 24.14 ± 1.07 | 24.52 ± 1.75 |
CTS-Pasp-5Fu | 22.01 ± 2.78 | 23.31 ± 2.39 | 25.15 ± 2.15 | 25.46 ± 2.08 | 25.53 ± 1.80 |
Table 2 The mean tumor volume (cm2) and inhibition rate of tumor growth (IR) in four groups
Groups | Before treatment | After treatment | ||||||
3 d | 7 d | IR | 10 d | IR | 14 d | IR | ||
NS | 0.11 ± 0.03 | 0.19 ± 0.05 | 0.33 ± 0.10 | 0.62 ± 0.28 | 0.80 ± 0.23 | |||
5-Fu | 0.12 ± 0.03 | 0.12 ± 0.04 | 0.24 ± 0.11 | 27.76% | 0.31 ± 0.19 | 50.27% | 0.33 ± 0.20 | 58.69% |
CTS-Pasp | 0.12 ± 0.03 | 0.19 ± 0.04 | 0.32 ± 0.10 | 2.80% | 0.54 ± 0.10 | 13.49% | 0.76 ± 0.26 | 5.58% |
CTS-Pasp-5Fu | 0.10 ± 0.01 | 0.11 ±0.04 | 0.13 ± 0.05 | 60.76% | 0.19 ± 0.05 | 68.99% | 0.23 ± 0.07 | 70.82% |
Table 3 Tumor weight (g) and tumor inhibition rate (TIR) at the end of experiment
Groups | Mean tumor weight (g) | TIR (%) |
NS | 1.47 ± 0.18 | - |
5-Fu group | 0.51 ± 0.11 | 65.30 |
CTS-Pasp group | 1.40 ± 0.13 | 5.09 |
CTS-Pasp-5Fu group | 0.40 ± 0.13 | 72.79 |
Table 4 WBC, TB, ALT, creatinine and cell colony culture in four groups
Groups | WBC(109/L) | TB(&mgr;mol/L) | ALT(U/L) | Creatinine (&mgr;mol/L) | CFU-GM (unit/plate) |
NS | 1.48 ± 0.84 | 1.24 ± 0.19 | 67.44 ± 19.33 | 27.83 ± 6.95 | 247 ± 18.06 |
5-Fu | 1.42 ± 0.50 | 15.08 ± 4.32 | 145.67 ± 42.52 | 22.98 ± 8.33 | 120 ± 8.25 |
CTS-Pasp | 1.50 ± 0.46 | 1.29 ± 0.67 | 65.43 ± 5.95 | 24.37 ± 4.89 | 241 ± 6.26 |
CTS-Pasp-5Fu | 1.54 ± 0.23 | 1.26 ± 0.49 | 58.84 ± 4.36 | 22.18 ± 6.18 | 239.6 ± 7.40 |
Table 5 Histological change in four groups
Groups | Tumor number | Score of histological tumor necrosis | |||
- | + | ++ | +++ | ||
NS | 8 | 3 | 5 | 0 | 0 |
CTS-Pasp | 8 | 2 | 6 | 0 | 0 |
5-Fu | 6 | 1 | 4 | 1 | 0 |
CTS-Pasp-5Fu | 8 | 0 | 4 | 3 | 1 |
Table 6 Expression of Bcl-2, Bax in four groups (n = 8)
- Citation: Zhang DY, Shen XZ, Wang JY, Dong L, Zheng YL, Wu LL. Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice. World J Gastroenterol 2008; 14(22): 3554-3562
- URL: https://www.wjgnet.com/1007-9327/full/v14/i22/3554.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3554